HANDOUTS AND VIDEO:
DOWNLOAD HANDOUTS PDF FILE
DOWNLOAD WEBINAR VIDEO
Procalcitonin (PCT) is an established biomarker, which is used to guide antibiotic treatment in septic patient. As an invaluable indicator, it shows high sensitivity and specificity for bacterial infection. Given the utility of PCT in clinical setting, variability in results from different commercial assays have been observed. In this webinar, participants will have the opportunity to review the clinical application of PCT, technology used for PCT measurements and also the challenges in terms of the standardization effort.
- Overview of sepsis and the clinical applications of PCT
- Understand the technology used for PCT measurements and the heterogeneity of PCT assays
- Realize the needs and importance in standardization of PCT assays (Key focus)
Matthias Grimmler, Ph.D, Professor of University of Applied Science Fresenius; Head of New Products / Technology & Head of Customer Business Care, DiaServe Laboratories; Head of Scientific & Medical Affairs, DiaSys Diagnostic Systems; member of International Federation of Clinical Chemistry (IFCC) Working Groups on the Standardization of Procalcitonin (WG-PCT); member of IFCC Working Groups on the Standardization of Apo-Lipoproteins (WG-APO MS); member of the IFCC Task Force on COVID-19; member of the Association of the German Diagnostics Industry.
Thomas Masetto, Head of R&D Immunoturbidimetry, DiaSys Diagnostic Systems; member of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (Società Italiana di Biochimica Clinica e Biologia Molecolare Clinica – SIBioC); member of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM); member of American Association for Clinical Chemistry (AACC); member of International Federation of Clinical Chemistry (IFCC) Working Groups on the Standardization of Procalcitonin (WG-PCT)
Vladimir Filatov, Ph.D; Group leader of Research & Development, HyTest. Dr. Filatov has worked in HyTest for 25 years and have led various development projects, e.g. PCT, IL-6, troponins and D-dimer. His work has been published in various well-recognized international journals, e.g. Clinical Chemistry and Clinical Biochemistry.